Mutation-Specific Cardiomyocyte Lines from Patients with Fabry Disease: A Sustainable In Vitro Model to Investigate Structure, Function, and Disease Mechanisms
Background: Fabry disease (FD) results from pathogenic <i>GLA</i> variants, causing lysosomal α-galactosidase A (α-GalA) deficiency and sphingolipid ceramide trihexoside (Gb3 or THC) accumulation. Disease phenotype varies widely but cardiomyopathy is commonly life-limiting. As a multisys...
Saved in:
| Main Authors: | Kathleen Nicholls, Andrea Wise, David Elliot, Menno ter Huurne, Maria Fuller, Sharon Ricardo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | International Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-8937/5/2/15 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fabry Disease Podocytes Reveal Ferroptosis as a Potential Regulator of Cell Pathology
by: Andrea F. Wise, et al.
Published: (2025-02-01) -
Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH)
by: K.P. Ng, et al.
Published: (2025-05-01) -
Fabry Disease - literature review
by: Krystian Wdowiak, et al.
Published: (2024-11-01) -
Modern Approach to Fabry Disease Diagnosis and Management in Children
by: Olga Ya. Smirnova, et al.
Published: (2024-02-01) -
Impaired plasma membrane calcium ATPase activity and mitochondrial dysfunction contribute to calcium dysregulation in Fabry disease-related painful neuropathy
by: Francesco Formaggio, et al.
Published: (2025-09-01)